TMPRSS15: A Potential Drug Target for Various Diseases (G5651)

Target Name: TMPRSS15

NCBI ID: G5651

TMPRSS15

TMPRSS15: A Potential Drug Target for Various Diseases

TMPRSS15 (Transmembrane Protease 15) is a protein that is expressed in various cell types, including neurons, muscle cells, and epithelial cells. It is a member of the superfamily of proteases, which are enzymes that remove the protein transmembrane domain from other proteins.

TMPRSS15 is involved in the regulation of various cellular processes, including cell signaling, cell adhesion, and cell survival. It has been shown to play a role in the development and progression of various diseases, including cancer, neurodegenerative diseases, and autoimmune diseases.

Due to its involvement in multiple cellular processes, TMPRSS15 has been identified as a potential drug target. Researchers have found that targeting TMPRSS15 with small molecules or antibodies can lead to the inhibition of various cellular processes that are associated with the disease.

One of the potential benefits of targeting TMPRSS15 is its potential to treat diseases that are currently treated with drugs that are toxic or have limited efficacy. For example, TMPRSS15 has been shown to be involved in the development of neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease. By targeting TMPRSS15, researchers hope to develop drugs that can slow the progression of these diseases and improve the quality of life for patients.

Another potential benefit of targeting TMPRSS15 is its potential to treat various types of cancer. TMPRSS15 has been shown to be involved in the development and progression of various types of cancer, including breast, lung, and ovarian cancer. By targeting TMPRSS15, researchers hope to develop drugs that can inhibit its activity and slow the growth of cancer cells.

Targeting TMPRSS15 has the potential to treat a wide range of diseases, including neurodegenerative diseases, autoimmune diseases, and various types of cancer. As research continues to advance, researchers are likely to identify even more potential applications for TMPRSS15 as a drug target.

Protein Name: Transmembrane Serine Protease 15

Functions: Responsible for initiating activation of pancreatic proteolytic proenzymes (trypsin, chymotrypsin and carboxypeptidase A). It catalyzes the conversion of trypsinogen to trypsin which in turn activates other proenzymes including chymotrypsinogen, procarboxypeptidases, and proelastases

The "TMPRSS15 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TMPRSS15 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets